Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

Jump to content

Racemorphan

From Wikipedia, the free encyclopedia
(Redirected from Morphanol)
Racemorphan
Legal status
Legal status
Identifiers
  • (±)-17-Methylmorphinan-3-ol
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
ECHA InfoCard100.005.499 Edit this at Wikidata
Chemical and physical data
FormulaC17H23NO
Molar mass257.377 g·mol−1
3D model (JSmol)
  • CN1CCC23CCCCC2C1Cc4ccc(O)cc34
  • InChI=1S/C17H23NO/c1-18-9-8-17-7-3-2-4-14(17)16(18)10-12-5-6-13(19)11-15(12)17/h5-6,11,14,16,19H,2-4,7-10H2,1H3
  • Key:JAQUASYNZVUNQP-UHFFFAOYSA-N

Racemorphan, or morphanol, is the racemic mixture of the two stereoisomers of 17-methylmorphinan-3-ol, each with differing pharmacology and effects:

Its analgesic activity is intermediate between Dextrorphan and Levorphanol.[2]

Racemorphan itself is under international control per the Single Convention on Narcotic Drugs 1961 and is therefore listed as a Schedule II Narcotic controlled substance in the US Controlled Substances Act 1970; it has an ACSCN of 9733 and in 2014 it had an aggregate annual manufacturing quota of zero.[3] The salts in use are hydrobromide (free base conversion ratio 0.741), hydrochloride (0.876), and tartrate (0.632).

See also

[edit]

References

[edit]
  1. Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
  2. Benson WM, Stefko PL, Randall LO (October 1953). "Comparative pharmacology of levorphan, racemorphan and dextrorphan and related methyl ethers". The Journal of Pharmacology and Experimental Therapeutics. 109 (2): 189–200. doi:10.1016/S0022-3565(25)05255-3. PMID 13097351.
  3. "Conversion Factors for Controlled Substances". www.deadiversion.usdoj.gov. Archived from the original on 2016-03-02. Retrieved 2016-02-27.